ArticleBioinformatics and biology insights2025
Evolutionary and epidemic dynamics of COVID-19 in Germany exemplified by three Bayesian phylodynamic case studies.
Article in Bioinformatics and biology insights, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The importance of genomic surveillance strategies for pathogens has been particularly evident during the coronavirus disease 2019 (COVID-19) pandemic, as genomic data from the causative agent, severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), have guided public health decisions worldwide. Bayesian phylodynamic inference, integrating epidemiology and evolutionary biology, has become an essential tool in genomic epidemiological surveillance. It enables the estimation of epidemiological parameters, such as the reproductive number, from pathogen sequence data alone. Despite the phylodynamic approach being widely adopted, the abundance of phylodynamic models often makes it challenging to select the appropriate model for specific research questions. This article illustrates the application of phylodynamic birth-death-sampling models in public health using genomic data, with a focus on SARS-CoV-2. Targeting researchers less familiar with phylodynamics, it introduces a comprehensive workflow, including the conceptualisation of a research study and detailed steps for data preprocessing and postprocessing. In addition, we demonstrate the versatility of birth-death-sampling models through three case studies from Germany, utilising the BEAST2 software and its model implementations. Each case study addresses a distinct research question relevant not only to SARS-CoV-2 but also to other pathogens: Case study 1 finds traces of a superspreading event at the start of an early outbreak, exemplifying how simple models for genomic data can provide information that would otherwise only be accessible through extensive contact tracing. Case study 2 compares transmission dynamics in a nosocomial outbreak to community transmission, highlighting distinct dynamics through integrative analysis. Case study 3 investigates whether local transmission patterns align with national trends, demonstrating how phylodynamic models can disentangle complex population substructure with little additional information. For each case study, we emphasise critical points where model assumptions and data properties may misalign and outline appropriate validation assessments. Overall, we aim to provide researchers with examples on using birth-death-sampling models in genomic epidemiology, balancing theoretical and practical aspects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.